Cargando…
Lysosomal Acid Lipase Deficiency: Therapeutic Options
Lysosomal acid lipase (LAL) deficiency is a metabolic (storage) disorder, encompassing a severe (Wolman disease) and attenuated (Cholesterol ester storage disease) subtype; both inherited as autosomal recessive traits. Cardinal clinical features include the combination of hepatic dysfunction and dys...
Autores principales: | Pastores, Gregory M, Hughes, Derralynn A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023879/ https://www.ncbi.nlm.nih.gov/pubmed/32103901 http://dx.doi.org/10.2147/DDDT.S149264 |
Ejemplares similares
-
Lysosomal Storage Disorders and Malignancy
por: Pastores, Gregory M., et al.
Publicado: (2017) -
Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa
por: Su, Kim, et al.
Publicado: (2016) -
Clinical Features of Lysosomal Acid Lipase Deficiency
por: Burton, Barbara K., et al.
Publicado: (2015) -
Lysosomal acid lipase deficiency – early diagnosis is the key
por: Strebinger, Georg, et al.
Publicado: (2019) -
Lysosomal Acid Lipase Deficiency: Genetics, Screening, and Preclinical Study
por: Mashima, Ryuichi, et al.
Publicado: (2022)